# Exercise-Induced Irisin: A Novel Strategy for Neuroinflammation Alleviation and Neurorepair in Diabetic Retinopathy

**Authors:** Hanlai Song, Yuxian Jiang, Shun Zhang, Chenmian Wu, Chaohua Deng, Weikun Hu

PMC · DOI: 10.3390/ijms27041849 · International Journal of Molecular Sciences · 2026-02-14

## TL;DR

This paper explores how exercise-induced irisin may help reduce neuroinflammation and promote repair in diabetic retinopathy.

## Contribution

The paper systematically reviews irisin's potential in alleviating neuroinflammation and promoting neural repair in diabetic retinopathy.

## Key findings

- Irisin improves mitochondrial function and reduces oxidative stress in retinal cells.
- Irisin inhibits pro-inflammatory factors and resists ferroptosis in diabetic retinopathy.
- Exercise-induced irisin may serve as a novel therapeutic strategy for neurorepair in DR.

## Abstract

Diabetic retinopathy (DR) stands as a classic microvascular complication of diabetes mellitus. DR is characterized by multidimensional pathological changes in retinal neurons, microvasculature and supportive cells, leading to an intricate damage network. It is predominantly marked by neuropathy, encompassing retinal neuronal dysfunction, aberrant activation of glial cells, and degeneration of synaptic structures. In severe instances, it can result in visual impairment and, in the worst-case scenario, blindness. As diabetes progresses, retinal nerve tissue frequently sustains damage owing to oxidative stress, inflammatory responses, and compromised mitochondrial function. Although the precise neuroprotective mechanisms remain elusive, exercise has the ability to bolster mitochondrial function in retinal cells, diminish oxidative stress, and curb inflammatory reactions, thereby safeguarding the neurophysiological function of the retina. Irisin is a myokine primarily secreted by skeletal muscles in response to exercise stimulation. Moreover, being produced in trace amounts across a variety of tissues, it has the capacity to regulate the physiological processes of multiple organs. Recent studies have indicated that irisin can exert powerful neuroprotective effects by enhancing cellular glucose uptake, improving mitochondrial function, inhibiting the expression of pro-inflammatory factors, and resisting ferroptosis. In this review, we systematically collated and synthesized existing evidence on irisin-related signaling pathways and comprehensively assessed its regulatory potential in alleviating neuroinflammation and promoting neural repair in diabetic retinopathy and offer insights into future research directions in this field.

## Linked entities

- **Proteins:** FNDC5 (fibronectin type III domain containing 5)
- **Diseases:** Diabetic retinopathy (MONDO:0005266), diabetes mellitus (MONDO:0005015)

## Full-text entities

- **Genes:** SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, ACSL4 (acyl-CoA synthetase long chain family member 4) [NCBI Gene 2182] {aka ACS4, FACL4, LACS4, MRX63, MRX68, XLID63}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, ITGAV (integrin subunit alpha V) [NCBI Gene 3685] {aka CD51, IDNDC, MSK8, VNRA, VTNR}, CLDN19 (claudin 19) [NCBI Gene 149461] {aka HOMG5}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NTRK1 (neurotrophic receptor tyrosine kinase 1) [NCBI Gene 4914] {aka MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA}, ATF4 (activating transcription factor 4) [NCBI Gene 468] {aka CREB-2, CREB2, TAXREB67, TXREB}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, RENBP (renin binding protein) [NCBI Gene 5973] {aka RBP, RNBP}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, MIR150 (microRNA 150) [NCBI Gene 406942] {aka MIRN150, miRNA150, mir-150}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, FNDC5 (fibronectin type III domain containing 5) [NCBI Gene 252995] {aka FRCP2, irisin}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, EIF2A (eukaryotic translation initiation factor 2A) [NCBI Gene 83939] {aka CDA02, EIF-2A, MST089, MSTP004, MSTP089}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, SERPINF1 (serpin family F member 1) [NCBI Gene 5176] {aka EPC-1, OI12, OI6, PEDF, PIG35}, AGER (advanced glycosylation end-product specific receptor) [NCBI Gene 177] {aka RAGE, SCARJ1, sRAGE}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, GPHB5 (glycoprotein hormone subunit beta 5) [NCBI Gene 122876] {aka B5, GPB5, ZLUT1}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, DDIT3 (DNA damage inducible transcript 3) [NCBI Gene 1649] {aka AltDDIT3, C/EBPzeta, CEBPZ, CHOP, CHOP-10, CHOP10}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, SLC7A11 (solute carrier family 7 member 11) [NCBI Gene 23657] {aka CCBR1, xCT}, STAT4 (signal transducer and activator of transcription 4) [NCBI Gene 6775] {aka DPMC, SLEB11}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 2908] {aka GCCR, GCR, GCRST, GR, GRL}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, SORD (sorbitol dehydrogenase) [NCBI Gene 6652] {aka HEL-S-95n, HMNR8, RDH, SDH, SORD1, SORDD}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, AKR1B1 (aldo-keto reductase family 1 member B) [NCBI Gene 231] {aka ADR, ALDR1, ALR2, AR}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** insulin resistance (MESH:D007333), bone loss (MESH:D001847), vascular damage (MESH:D057772), DR (MESH:D003930), BRB (MESH:D012173), hypertrophy (MESH:D006984), diabetic neuropathy (MESH:D003929), NPDR (OMIM:603933), Diabetic Complications (MESH:D048909), diabetic cardiomyopathy (MESH:D058065), hyperglycemic (MESH:D006944), capillary occlusion (MESH:D001157), reperfusion injury (MESH:D015427), gliosis (MESH:D005911), microvascular occlusion (MESH:D017566), renal tubular injury (MESH:D015499), photoreceptor cell degeneration (MESH:D002292), apoptosis (MESH:D065703), cognitive impairment (MESH:D003072), neuropathy (MESH:D009422), diabetic nephropathy (MESH:D003928), BRB impairment (MESH:D012164), T1DM (MESH:D003922), glomerular injury (MESH:D007674), T2DM (MESH:D003924), neuronal damage (MESH:D009410), Neuroinflammation (MESH:D000090862), glucose metabolism disorders (MESH:D044882), vascular abnormalities (MESH:D014652), diabetes (MESH:D003920), neurotoxic (MESH:D020258), mitochondrial damage (MESH:D028361), vision loss (MESH:D014786), metabolic syndrome (MESH:D024821), Hyperglycemia (MESH:D006943), fibrosis (MESH:D005355), Chronic inflammation (MESH:D007249), injury (MESH:D014947), neurodegeneration (MESH:D019636), neuronal and glial dysfunction (MESH:D004194), retinal edema (MESH:D010211), hypoxia (MESH:D000860), blindness (MESH:D001766), proteinuria (MESH:D011507), metabolic disorders (MESH:D008659), Metabolic dysregulation (MESH:D021081), neuronal dysfunction (MESH:D009461), ischemia (MESH:D007511), vascular complications (MESH:D003925), myocardial (MESH:D009202), hemorrhages (MESH:D006470), obese (MESH:D009765), of synaptic structures (MESH:D020914), vasogenic edema (MESH:D001929), diastolic dysfunction (MESH:D018487)
- **Chemicals:** fatty acids (MESH:D005227), MDA (MESH:D008315), NADPH (MESH:D009249), H2O2 (MESH:D006861), superoxide (MESH:D013481), ACEI (-), ROS (MESH:D017382), hexosamine (MESH:D006595), creatinine (MESH:D003404), Glucosamine (MESH:D005944), glucose (MESH:D005947), NAD+ (MESH:D009243), melanin (MESH:D008543), urea nitrogen (MESH:C530477), lipid (MESH:D008055), astaxanthin (MESH:C005948), GSH (MESH:D005978), fructose (MESH:D005632), LPOs (MESH:D008054), polyol (MESH:C024617), lactate (MESH:D019344), oxygen (MESH:D010100), retinol (MESH:D014801), iron (MESH:D007501), AGEs (MESH:D017127), Sorbitol (MESH:D013012)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HT22 — Mus musculus (Mouse), Transformed cell line (CVCL_0321), RPE — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941363/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12941363/full.md

## References

187 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941363/full.md

---
Source: https://tomesphere.com/paper/PMC12941363